Utility of next generation sequencing for differentiating malignant PEComa from metastatic melanoma.

Elizabeth Paver Karina Aivazian Fiona Maclean Georgina V Long Andrew J Spillane James S Wilmott Richard A Scolyer

Pathology

Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, NSW, Australia. Electronic address:

Published: June 2023

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.pathol.2022.08.011	DOI Listing

Publication Analysis

Top Keywords

utility generation

generation sequencing

sequencing differentiating

differentiating malignant

malignant pecoma

pecoma metastatic

metastatic melanoma

utility

sequencing

differentiating

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!